Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 785892, 10 pages
http://dx.doi.org/10.1155/2013/785892
Research Article

Helicobacter pylori Infection in Dialysis Patients: A Meta-Analysis

1Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
2First Clinical Medical College of Nanjing Medical University, Nanjing 210029, China

Received 10 July 2013; Revised 5 September 2013; Accepted 19 September 2013

Academic Editor: Khean Lee Goh

Copyright © 2013 Min Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Rocha, D. M. Queiroz, E. N. Mendes et al., “Indirect immunofluorescence determination of the frequency of anti-H. pylori antibodies in Brazilian blood donors,” Brazilian Journal of Medical and Biological Research, vol. 25, no. 7, pp. 683–689, 1992. View at Google Scholar · View at Scopus
  2. J. J. Huang, C. J. Huang, M. K. Ruaan, K. W. Chen, T. S. Yen, and B. S. Sheu, “Diagnostic efficacy of 13C-urea breath test for Helicobacter pylori infection in hemodialysis patients,” The American Journal of Kidney Diseases, vol. 36, no. 1, pp. 124–129, 2000. View at Google Scholar · View at Scopus
  3. B. van Vlem, R. Schoonjans, R. Vanholder et al., “Delayed gastric emptying in dyspeptic chronic hemodialysis patients,” The American Journal of Kidney Diseases, vol. 36, no. 5, pp. 962–968, 2000. View at Google Scholar · View at Scopus
  4. H. Araki, R. Miyazaki, T. Matsuda, F. Gejyo, and I. Koni, “Significance of serum pepsinogens and their relationship to Helicobacter pylori infection and histological gastritis in dialysis patients,” Nephrology Dialysis Transplantation, vol. 14, no. 11, pp. 2669–2675, 1999. View at Google Scholar · View at Scopus
  5. S. L. Hazell and A. Lee, “Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers,” The Lancet, vol. 2, no. 8497, pp. 15–17, 1986. View at Google Scholar · View at Scopus
  6. H. Khedmat, M. Ahmadzad-Asl, M. Amini et al., “Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients,” Transplantation Proceedings, vol. 39, no. 4, pp. 1003–1007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Schoonjans, V. B. Van, W. Vandamme et al., “Dyspepsia and gastroparesis in chronic renal failure: the role of Helicobacter pylori,” Clinical Nephrology, vol. 57, no. 3, pp. 201–207, 2002. View at Google Scholar · View at Scopus
  8. S. Aydemir, S. Boyacioglu, G. Gur et al., “Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin,” World Journal of Gastroenterology, vol. 11, no. 6, pp. 842–845, 2005. View at Google Scholar · View at Scopus
  9. U. Gladziwa, G. Haase, S. Handt et al., “Prevalence of Helicobacter pylori in patients with chronic renal failure,” Nephrology Dialysis Transplantation, vol. 8, no. 4, pp. 301–306, 1993. View at Google Scholar · View at Scopus
  10. D. Jaspersen, W. Fassbinder, P. Heinkele et al., “Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function,” Journal of Gastroenterology, vol. 30, no. 5, pp. 585–588, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Sugimoto, K. Sakai, M. Kita, J. Imanishi, and Y. Yamaoka, “Prevalence of Helicobacter pylori infection in long-term hemodialysis patients,” Kidney International, vol. 75, no. 1, pp. 96–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Korzonek, L. Szymaniak, S. Giedrys-Kalemba, and K. Ciechanowski, “Is it necessary to treat Helicobacter pylori infection in patients with end-stage renal failure and renal transplant recipients?” Polskie Archiwum Medycyny Wewnetrznej, vol. 111, no. 3, pp. 297–304, 2004. View at Google Scholar · View at Scopus
  13. S. Shousha, A. H. Arnaout, S. H. Abbas, and R. A. Parkins, “Antral Helicobacter pylori in patients with chronic renal failure,” Journal of Clinical Pathology, vol. 43, no. 5, pp. 397–399, 1990. View at Google Scholar · View at Scopus
  14. W. Krawczyk, E. Górna, J. Suwala et al., “Frequency of Helicobacter pylori infection in uremic hemodialyzed patients with antral gastritis,” Nephron, vol. 74, no. 3, pp. 621–622, 1996. View at Google Scholar · View at Scopus
  15. O. Ozgür, S. Boyacioğlu, M. Ozdoğan, G. Gür, H. Telatar, and M. Haberal, “Helicobacter pylori infection in haemodialysis patients and renal transplant recipients,” Nephrology Dialysis Transplantation, vol. 12, pp. 289–291, 1997. View at Google Scholar
  16. R. J. L. F. Loffeld, H. G. Peltenburg, H. V. D. Oever, and E. Stobberingh, “Prevalence of Helicobacter pylori antibodies in patients on chronic intermittent haemodialysis,” Nephron, vol. 59, no. 2, pp. 250–253, 1991. View at Google Scholar · View at Scopus
  17. F. Luzza, M. Imeneo, M. Maletta et al., “Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serology,” Nephrology Dialysis Transplantation, vol. 11, no. 1, pp. 120–124, 1996. View at Google Scholar · View at Scopus
  18. F. Fabrizi and P. Martin, “Helicobacter pylori infection in patients with end-stage renal disease,” International Journal of Artificial Organs, vol. 23, no. 3, pp. 157–164, 2000. View at Google Scholar · View at Scopus
  19. M. K. H. Asl and H. Nasri, “Prevalence of Helicobacter pylori infection in maintenance hemodialysis patients with non-ulcer dyspepsia,” Saudi Journal of Kidney Diseases and Transplantation, vol. 20, no. 2, pp. 223–226, 2009. View at Google Scholar · View at Scopus
  20. M. J. Lysaght, “Maintenance dialysis population dynamics: current trends and long-term implications,” Journal of the American Society of Nephrology, vol. 13, supplement 1, pp. S37–S40, 2001. View at Google Scholar · View at Scopus
  21. G. Gür, S. Boyacioglu, C. Gül et al., “Impact of Helicobacter pylori infection on serum gastrin in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 14, no. 11, pp. 2688–2691, 1999. View at Google Scholar · View at Scopus
  22. A. Yildiz, F. Beşişik, V. Akkaya et al., “Helicobacter pylori antibodies in hemodialysis patients and renal transplant recipients,” Clinical Transplantation, vol. 13, no. 1, part 1, pp. 13–16, 1999. View at Google Scholar · View at Scopus
  23. H. Tamura, H. Tokushima, M. Murakawa et al., “Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients,” Nephrology Dialysis Transplantation, vol. 14, no. 1, pp. 113–117, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Blusiewicz, G. Rydzewska, and A. Rydzewski, “Gastric juice ammonia and urea concentrations and their relation to gastric mucosa injury in patients maintained on chronic hemodialysis,” Roczniki Akademii Medycznej w Białymstoku, vol. 50, pp. 188–192, 2005. View at Google Scholar · View at Scopus
  25. M. R. Khazaei, M. H. Imanieh, and G. H. Al-Hashemi, “Gastrointestinal evaluation in pediatric kidney transplantation candidates,” Iranian Journal of Kidney Diseases, vol. 2, no. 1, pp. 40–45, 2008. View at Google Scholar · View at Scopus
  26. F. P. Gioè, B. Cudia, G. Romano et al., “Role and clinical importance of Helicobacter pylori infection in hemodialysis patients,” Il Giornale di Chirurgia, vol. 29, no. 3, pp. 81–84, 2008. View at Google Scholar · View at Scopus
  27. M. K. H. Asl and H. Nasri, “Prevalence of Helicobacter pylori infection in maintenance hemodialysis patients with non-ulcer dyspepsia,” Saudi Journal of Kidney Diseases and Transplantation, vol. 20, no. 2, pp. 223–226, 2009. View at Google Scholar · View at Scopus
  28. W. C. Chang, Y. I. Jo, H. S. Park et al., “Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients,” Clinical and Experimental Nephrology, vol. 14, no. 5, pp. 469–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Google Scholar · View at Scopus
  30. P. Malfertheiner, Y. I. Jo, F. Megraud, C. A. O’Morain et al., “Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report,” Gut, vol. 61, no. 5, pp. 646–664, 2012. View at Google Scholar
  31. F. Nakajima, M. Sakaguchi, K. Amemoto et al., “Helicobacter pylori in patients receiving long-term dialysis,” The American Journal of Nephrology, vol. 22, no. 5-6, pp. 468–472, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Sato, K. Murakami, T. Okimoto, K. Watanabe, M. Kodama, and T. Fujioka, “Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura,” Journal of Gastroenterology, vol. 46, no. 8, pp. 991–997, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Zhou, C. Zhang, J. Wu, and G. Zhang, “Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies,” Diabetes Research and Clinical Practice, vol. 99, pp. 200–208, 2013. View at Google Scholar
  34. G. A. Block, P. Raggi, A. Bellasi, L. Kooienga, and D. M. Spiegel, “Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients,” Kidney International, vol. 71, no. 5, pp. 438–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. W. D. Neithercut, P. A. Rowe, A. M. el Nujumi, S. Dahill, and K. E. L. McColl, “Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure,” Journal of Clinical Pathology, vol. 46, no. 6, pp. 544–547, 1993. View at Google Scholar · View at Scopus
  36. A. F. de Vecchi, M. Quatrini, F. Boni et al., “Epidemiology of Helicobacter pylori in dialysis patients,” Peritoneal Dialysis International, vol. 15, no. 2, pp. 178–179, 1995. View at Google Scholar · View at Scopus
  37. H. Paimela, S. Stenman, and M. Kekki, “Chronic gastritis and gastric acid secretion in uraemic and renal transplant patients,” Hepatogastroenterology, vol. 32, no. 1, pp. 15–19, 1985. View at Google Scholar · View at Scopus
  38. I. R. Hwang, T. Kodama, S. Kikuchi et al., “Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection,” Gastroenterology, vol. 123, no. 6, pp. 1793–1803, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Nakajima, M. Sakaguchi, H. Oka et al., “Prevalence of Helicobacter pylori antibodies in long-term dialysis patients,” Nephrology, vol. 9, no. 2, pp. 73–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Antoniou, A. Dimitriadis, M. Kliridou, K. Pavlitou, H. Batzili, and E. Malaka, “Prevalence of Helicobacter pylori antibodies in CAPD patients,” Nephron, vol. 75, no. 3, pp. 358–359, 1997. View at Google Scholar · View at Scopus
  41. F. Mortazavi and M. Rafeey, “Endoscopic findings and Helicobacter pylori in children on long-term hemodialysis,” Pakistan Journal of Biological Sciences, vol. 11, no. 14, pp. 1840–1843, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Rasmi, S. Farshid, and K. Makhdomi, “Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection,” Saudi Journal of Kidney Diseases and Transplantation, vol. 23, no. 3, pp. 489–492, 2012. View at Google Scholar
  43. E. M. de Bustillo, J. A. S. Tomero, J. C. Sanz et al., “Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients,” Nephron, vol. 79, no. 1, pp. 55–60, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. G. J. A. Offerhaus, J. Kreuning, R. M. Valentijn et al., “Campylobacter pylori: prevalence and significance in patients with chronic renal failure,” Clinical Nephrology, vol. 32, no. 5, pp. 239–241, 1989. View at Google Scholar · View at Scopus
  45. O. Marsenic, A. Peco-Antic, V. Perisic, V. Virijevic, D. Kruscic, and M. Kostic, “Upper gastrointestinal lesions in children on chronic haemodialysis,” Nephrology Dialysis Transplantation, vol. 18, no. 12, pp. 2687–2688, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Emir, G. Bereket, S. Boyacioǧlu, B. Varan, H. Tunali, and M. Haberal, “Gastroduodenal lesions and Helicobacter pylori in children with end-stage renal disease,” Pediatric Nephrology, vol. 14, no. 8-9, pp. 837–840, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Ala-Kaila, P. Vaajalahti, A. L. Karvonen, and M. Kokki, “Gastric Helicobacter and upper gastrointestinal symptoms in chronic renal failure,” Annals of Medicine, vol. 23, no. 4, pp. 403–406, 1991. View at Google Scholar · View at Scopus
  48. H. Tokushima, H. Tamura, M. Murakawa et al., “Eradication of Helicobacter pylori restores elevation of serum gastrin concentrations in patients with end-stage renal disease,” Internal Medicine, vol. 37, no. 5, pp. 435–439, 1998. View at Google Scholar · View at Scopus
  49. H. Tokushima, “Role of Helicobacter pylori in gastro-duodenal mucosal lesions in patients with end-stage renal disease under dialysis treatment,” Nippon Jinzo Gakkai Shi, vol. 37, no. 9, pp. 503–510, 1995. View at Google Scholar · View at Scopus
  50. M. Seyyedmajidi, K. Falaknazi, D. Mirsattari et al., “Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: a randomised clinical trial,” Arab Journal of Gastroenterology, vol. 12, no. 3, pp. 150–153, 2011. View at Publisher · View at Google Scholar · View at Scopus